The Silicon Valley startup Preventive, founded by Lucas Harrington, aims to create genetically engineered babies by editing human embryos to eliminate hereditary diseases, having raised $30 million from investors like Sam Altman and Brian Armstrong. Harrington emphasizes the need for safe and transparent technology, advocating for rigorous research and regulatory oversight before proceeding with embryo editing. This initiative follows previous controversies surrounding gene editing, notably the case of He Jiankui, who faced legal repercussions for his experiments. While U.S. federal law restricts funding for germline gene therapy research, private funding avenues remain open, pending FDA approval for clinical use.
Want More Context? 🔎
